What's the mechanism of action for tucatinib?
Tucatinib (Tukysa) is a human epidermal growth factor receptor-2 (HER2) inhibitor that works by blocking the HER2 protein to help slow or stop cancer cell growth in patients with advanced breast cancer or colorectal cancer. Some cancers have an over-expression of the HER2 protein causing increased growth and spread of cancer cells.
Tucatinib, an oral targeted drug therapy, is very selective for the HER2 protein and works inside the cell. Tucatinib binds to tyrosine kinase (an enzyme) of HER2, reducing PI3-kinase and MAP-kinase signaling. Reduced signaling helps to block cell growth and leads to cell death. Tucatinib is classified as a HER2 tyrosine kinase inhibitor.
Related information: List of HER2 Inhibitors
How is tucatinib used?
- Tucatinib (Tukysa) is used with the medicines trastuzumab (Herceptin) and capecitabine (Xeloda) in adult patients with HER2-positive breast cancer, including cancer that has spread to the brain. It is given to patients who have already received one or more anti-HER2 breast cancer treatments, but are no longer effective.
- It is also used in combination with trastuzumab to treat adult patients with RAS wild-type HER2-positive unresectable or metastatic colorectal cancer that has progressed following treatment with fluoropyrimidine-, oxaliplatin-, and irinotecan-based chemotherapy.
- It is used when the cancer has spread in the body (metastatic) or cannot be removed with surgery (unresectable).
The FDA approved Tukysa for colorectal cancer under an "accelerated approval". This means that continued approval for this use may depend upon results of further clinical studies looking at its effectiveness in colorectal cancer.
This is not all the information you need to know about Tukysa (tucatinib) for safe and effective use and does not take the place of talking to your doctor about your treatment. Review the full product information here, and discuss this information and any questions you have with your doctor or other health care provider.
Related questions
References
- Tukysa (tucatinib) product information. Seagen. Bothell, WA. Revised 1/2023. Accessed Jan 25, 2023 at https://docs.seagen.com/TUKYSA_Full_Ltr_Master.pdf
- Tukysa.com. Mechanism of Action. Seagen Inc. Accessed April 22, 2021 at https://www.tukysahcp.com/videolibrary
Read next
What is the FOLFIRI chemo regimen and how does it work?
FOLFIRI is a widely used chemotherapy regimen that contains folinic acid (leucovorin), fluorouracil (5-FU), and irinotecan (Camptosar). Administered in 2-week cycles, these medications work together to target and destroy rapidly dividing cancer cells, slowing tumor growth and improving survival. It is primarily used for treating metastatic colorectal cancer, but also used for other gastrointestinal cancers.
Continue reading
What is the FOLFOX chemo regimen and is it effective?
FOLFOX is a combination chemotherapy regimen primarily used to treat colorectal cancer, in both early-stage and advanced-stage settings. It includes folinic acid (leucovorin), fluorouracil, and oxaliplatin. These drugs work together to destroy cancer cells by disrupting their DNA synthesis and function.
Continue reading
What is the success rate of Keytruda?
In general, PD-1 immune checkpoint inhibitors like Keytruda have been shown to significantly prolong overall survival (OS) in some patients with various cancer types, but Keytruda does not always work for everyone. Continue reading
Related medical questions
- How long does it take for Keytruda to work?
- What is the CAPOX chemotherapy regimen?
- Why do you need to take Xeloda with food?
- Pembrolizumab vs. nivolumab: How do they compare?
- How long does oxaliplatin stay in your system?
- How many cycles of oxaliplatin can you have?
- How effective is Lumakras, what's the survival rate?
- What is the difference between Mvasi and Avastin?
- How long does Lonsurf increase survival in colorectal cancer?
- How effective are Opdivo and Yervoy when taken together?
- Opdivo vs Opdivo Qvantig: What is the Difference?
- What is Braftovi used to treat?
- Common Types of Cancer Medications
- What is the strongest chemotherapy drug for breast cancer?
- Why are my nipples sore? 7 possible causes
- How long do letrozole side effects last?
- What happens when you stop taking letrozole?
- Does anastrozole cause hair loss?
- What is the TC chemo regimen and how does it treat breast cancer?
- How do you relieve joint pain associated with tamoxifen or Aromasin?
- How long does Ibrance extend life?
- Is letrozole a form of chemotherapy?
- What does anastrozole do to your body?
- What are monoclonal antibodies?
- What is the success rate of Enhertu in metastatic breast cancer?
- What is the lifetime or cumulative dose for Adriamycin?
- Does Femara make your hair fall out?
- Why give Taxol (Paxel) before carboplatin?
- What is Herceptin? Is Herceptin a chemo drug? How does it work?
- Does letrozole affect blood sugar levels?
Drug information
Related support groups
- Tucatinib (3 questions, 3 members)
- Tukysa (3 questions, 3 members)
- Colorectal Cancer (22 questions, 53 members)
- Breast Cancer (129 questions, 310 members)